{"transactions":[{"id":1294160,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-27T23:10:00.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":70000,"derivative":{"exercise_price":11.14,"expiration_date":"2035-01-23","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001746473-25-000017","document":"wk-form4_1738019393.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647325000017/wk-form4_1738019393.xml","form_type":"4"}},{"id":1294159,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2025-01-27T23:10:00.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":105544,"source":{"system":"sec-edgar","filing":"0001746473-25-000017","document":"wk-form4_1738019393.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647325000017/wk-form4_1738019393.xml","form_type":"4"}},{"id":1297191,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2025-01-22T22:55:27.000Z","date":"2025-01-22","kind":"sale","planned":true,"acquired":false,"shares":10230,"price":10.9934,"value":112462.482,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $10.88 to $11.21, inclusive. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4."}],"balance_after":70544,"source":{"system":"sec-edgar","filing":"0001746473-25-000001","document":"wk-form4_1737586520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647325000001/wk-form4_1737586520.xml","form_type":"4"}},{"id":1297190,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2025-01-22T22:55:27.000Z","date":"2025-01-17","kind":"sale","planned":true,"acquired":false,"shares":13270,"price":11.2011,"value":148638.597,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a nondiscretionary sale by the plan on behalf of the Reporting Person in a manner intended to satisfy the requirements of Rule 10b5-1. The sale price of the Reporting Person's shares represents the weighted average of all shares sold by a broker at prices ranging from $11.03 to $11.695, inclusive, on January 17, 2025 and January 21, 2025 on behalf of a group of employees of the Issuer, including the Reporting Person, to satisfy the payment of withholding tax liability in connection with the vesting of previously granted restricted stock units. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold on behalf of the group of employees of the Issuer at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":80774,"source":{"system":"sec-edgar","filing":"0001746473-25-000001","document":"wk-form4_1737586520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647325000001/wk-form4_1737586520.xml","form_type":"4"}},{"id":1455135,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2024-07-12T22:15:25.000Z","date":"2024-07-10","kind":"sale","planned":true,"acquired":false,"shares":7656,"price":11.56,"value":88503.36,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a nondiscretionary sale by the plan on behalf of the Reporting Person in a manner intended to satisfy the requirements of Rule 10b5-1. The sale price of the Reporting Person's shares represents the weighted average of all shares sold by a broker at prices ranging from $10.785 to $12.58, inclusive, between July 10, 2024 and July 11, 2024 on behalf of a group of employees of the Issuer, including the Reporting Person, to satisfy the payment of withholding tax liability in connection with the vesting of previously granted performance-vested stock units. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold on behalf of the group of employees of the Issuer at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":94044,"source":{"system":"sec-edgar","filing":"0001746473-24-000121","document":"wk-form4_1720822518.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647324000121/wk-form4_1720822518.xml","form_type":"4"}},{"id":1455788,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2024-07-11T20:41:53.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":14954,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 28, 2022, the Reporting Person was granted 54,374 performance-vested stock units, the vesting of which were subject to the achievement of various pre-established performance criteria. On July 9, 2024, the Compensation Committee of the Issuer's Board of Directors certified the achievement of the performance criteria tied to the company's total shareholder return relative to the Nasdaq Biotechnology Index, resulting in the vesting of 14,954 shares."}],"balance_after":101700,"source":{"system":"sec-edgar","filing":"0001746473-24-000111","document":"wk-form4_1720730506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647324000111/wk-form4_1720730506.xml","form_type":"4"}},{"id":1671818,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-24T21:57:33.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":63000,"derivative":{"exercise_price":17.44,"expiration_date":"2034-01-23","underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001746473-24-000015","document":"wk-form4_1706133440.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647324000015/wk-form4_1706133440.xml","form_type":"4"}},{"id":1671817,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2024-01-24T21:57:33.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":31500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units that vest in three substantially equal annual installments beginning January 16, 2024, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":86746,"source":{"system":"sec-edgar","filing":"0001746473-24-000015","document":"wk-form4_1706133440.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647324000015/wk-form4_1706133440.xml","form_type":"4"}},{"id":1674919,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2024-01-19T22:11:16.000Z","date":"2024-01-17","kind":"sale","planned":true,"acquired":false,"shares":5197,"price":17.23,"value":89544.31,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a nondiscretionary sale by the plan on behalf of the Reporting Person in a manner intended to satisfy the requirements of Rule 10b5-1. The sale price of the Reporting Person's shares represents the weighted average of all shares sold by a broker at prices ranging from $16.33 to $17.90, inclusive, between January 17, 2024 and January 18, 2024 on behalf of a group of employees of the Issuer, including the Reporting Person, to satisfy the payment of withholding tax liability in connection with the vesting of previously granted restricted stock units. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold on behalf of the group of employees of the Issuer at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":55246,"source":{"system":"sec-edgar","filing":"0001746473-24-000001","document":"wk-form4_1705702265.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000174647324000001/wk-form4_1705702265.xml","form_type":"4"}},{"id":1824642,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-07-21T20:40:57.000Z","date":"2023-07-20","kind":"sale","planned":true,"acquired":false,"shares":4755,"price":17.55,"value":83450.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $17.45 to $17.67, inclusive. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":60443,"source":{"system":"sec-edgar","filing":"0001209191-23-043085","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000120919123043085/doc4.xml","form_type":"4"}},{"id":1826594,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-07-20T00:31:31.000Z","date":"2023-07-17","kind":"sale","planned":true,"acquired":false,"shares":12778,"price":18.0091,"value":230120.2798,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a nondiscretionary sale by the plan on behalf of the Reporting Person in a manner intended to satisfy the requirements of Rule 10b5-1. The sale price of the Reporting Person's shares represents the weighted average of all shares sold by a broker at prices ranging from $17.63 to $18.47, inclusive, between July 17, 2023 and July 19, 2023 on behalf of a group of employees of the Issuer, including the Reporting Person, to satisfy the payment of withholding tax liability in connection with the vesting of previously granted performance-vested stock units. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold on behalf of the group of employees of the Issuer at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":65198,"source":{"system":"sec-edgar","filing":"0001209191-23-042834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000120919123042834/doc4.xml","form_type":"4"}},{"id":1827557,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-07-18T23:26:18.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":27187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 28, 2022, the Reporting Person was granted 54,374 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On July 14, 2023, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 27,187 shares."}],"balance_after":77976,"source":{"system":"sec-edgar","filing":"0001209191-23-042662","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000120919123042662/doc4.xml","form_type":"4"}},{"id":1931750,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-04-03T23:07:00.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":200,"price":27.455,"value":5491.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.27 to $27.64, inclusive. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (5) to this Form 4."}],"balance_after":50789,"source":{"system":"sec-edgar","filing":"0001209191-23-022376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000120919123022376/doc4.xml","form_type":"4"}},{"id":1931749,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-04-03T23:07:00.000Z","date":"2023-04-03","kind":"sale","planned":true,"acquired":false,"shares":2677,"price":26.7371,"value":71575.2167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $26.24 to $27.17, inclusive. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3) to this Form 4."}],"balance_after":50989,"source":{"system":"sec-edgar","filing":"0001209191-23-022376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000120919123022376/doc4.xml","form_type":"4"}},{"id":1931748,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-04-03T23:07:00.000Z","date":"2023-03-30","kind":"sale","planned":true,"acquired":false,"shares":4874,"price":26.5209,"value":129262.8666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a nondiscretionary sale by the plan established on behalf of the Reporting Person on July 28, 2022 in a manner intended to satisfy the requirements of Rule 10b5-1. The sale price of the Reporting Person's shares represents the weighted average of all shares sold by a broker at prices ranging from $25.88 to $27.235, inclusive, on March 30, 2023 and March 31, 2023 on behalf of a group of employees of the Issuer, including the Reporting Person, to satisfy the payment of withholding tax liability in connection with the vesting of previously granted performance-vested stock units. The Reporting Person undertakes to provide Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold on behalf of the group of employees of the Issuer at each separate price within the range set forth in footnote (1) to this Form 4."}],"balance_after":53666,"source":{"system":"sec-edgar","filing":"0001209191-23-022376","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000120919123022376/doc4.xml","form_type":"4"}},{"id":1933716,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-03-31T22:05:43.000Z","date":"2023-03-29","kind":"grant","planned":false,"acquired":true,"shares":13593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 28, 2022, the Reporting Person was granted 54,375 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On March 29, 2023, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 13,593 shares."}],"balance_after":58540,"source":{"system":"sec-edgar","filing":"0001209191-23-021927","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000120919123021927/doc4.xml","form_type":"4"}},{"id":2043424,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-28T00:15:31.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":55000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":55000,"derivative":{"exercise_price":34.65,"expiration_date":"2033-01-24","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001140361-23-003179","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036123003179/form4.xml","form_type":"4"}},{"id":2043423,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-01-28T00:15:31.000Z","date":"2023-01-25","kind":"grant","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These are restricted stock units that vest in three equal annual installments beginning January 16, 2023, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":44947,"source":{"system":"sec-edgar","filing":"0001140361-23-003179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036123003179/form4.xml","form_type":"4"}},{"id":2046143,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-26T02:00:46.000Z","date":"2023-01-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to such option vested on October 1, 2021 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":98240,"derivative":{"exercise_price":24.32,"expiration_date":"2030-10-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-23-002785","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036123002785/form4.xml","form_type":"4"}},{"id":2046142,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Stock Option (right to buy)","published_at":"2023-01-26T02:00:46.000Z","date":"2023-01-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":77000,"derivative":{"exercise_price":11.86,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001140361-23-002785","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036123002785/form4.xml","form_type":"4"}},{"id":2046141,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-01-26T02:00:46.000Z","date":"2023-01-23","kind":"sale","acquired":false,"shares":20000,"price":34.1939,"value":683878.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022."}],"balance_after":5947,"source":{"system":"sec-edgar","filing":"0001140361-23-002785","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036123002785/form4.xml","form_type":"4"}},{"id":2046140,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-01-26T02:00:46.000Z","date":"2023-01-23","kind":"exercise","acquired":true,"shares":10000,"price":24.32,"value":243200.0,"ownership":{"direct":true},"balance_after":25947,"source":{"system":"sec-edgar","filing":"0001140361-23-002785","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036123002785/form4.xml","form_type":"4"}},{"id":2046139,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2023-01-26T02:00:46.000Z","date":"2023-01-23","kind":"exercise","acquired":true,"shares":10000,"price":11.86,"value":118600.0,"ownership":{"direct":true},"balance_after":15947,"source":{"system":"sec-edgar","filing":"0001140361-23-002785","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036123002785/form4.xml","form_type":"4"}},{"id":2076542,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2022-12-23T22:34:01.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":2928,"price":19.3753,"value":56730.8784,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 4, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $18.86 to $19.57, inclusive. The Reporting Person undertakes to provide to Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4."}],"balance_after":5947,"source":{"system":"sec-edgar","filing":"0001140361-22-046917","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036122046917/form4.xml","form_type":"4"}},{"id":2078413,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2022-12-22T02:32:30.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":4719,"price":19.1024,"value":90144.2256,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker at prices ranging from $18.4049 to $19.64, inclusive, on December 20, 2022 and December 21, 2022 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employee in connection with the vesting of previously granted performance-vested stock units. The Reporting Person undertakes to provide to Pliant Therapeutics, Inc., any security holder of Pliant Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold on behalf of the group of employees of the Issuer at each separate price within the range set forth in footnote (2) to this Form 4."}],"balance_after":8875,"source":{"system":"sec-edgar","filing":"0001140361-22-046568","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036122046568/form4.xml","form_type":"4"}},{"id":2078412,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"officer":true,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Common Stock","published_at":"2022-12-22T02:32:30.000Z","date":"2022-12-19","kind":"grant","acquired":true,"shares":13594,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 28, 2022, the Reporting Person was granted 54,375 performance-vested stock units, the vesting of which are subject to the achievement of various pre-established performance criteria. On December 19, 2022, the Compensation Committee of the Issuer's Board of Directors certified the achievement of an operational performance criteria, resulting in the vesting of 13,594 shares."}],"balance_after":13594,"source":{"system":"sec-edgar","filing":"0001140361-22-046568","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000114036122046568/form4.xml","form_type":"4"}},{"id":2415756,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-03T01:16:45.000Z","date":"2022-01-26","kind":"grant","acquired":true,"shares":87000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2022, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":87000,"derivative":{"exercise_price":11.86,"expiration_date":"2032-01-25","underlying":"Common Stock","underlying_shares":87000},"source":{"system":"sec-edgar","filing":"0001567619-22-002401","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000156761922002401/doc1.xml","form_type":"4"}},{"id":2894667,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel & Corp. Sec'y"}}],"security":"Stock Option (right to buy)","published_at":"2021-01-27T01:00:08.000Z","date":"2021-01-23","kind":"grant","acquired":true,"shares":15520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to such option vest and become exercisable in substantially equal installments on each monthly anniversary of January 1, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":15520,"derivative":{"exercise_price":26.5,"expiration_date":"2031-01-22","underlying":"Common Stock","underlying_shares":15520},"source":{"system":"sec-edgar","filing":"0000899243-21-003379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000089924321003379/doc4.xml","form_type":"4"}},{"id":3007783,"issuer":{"id":7022,"kind":"organization","name":"PLIANT THERAPEUTICS, INC."},"owners":[{"id":83855,"kind":"person","name":"Ouimette Mike","position":1,"cik":"0001822619","reported_name":"Ouimette Mike","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-14T00:00:11.000Z","date":"2020-10-09","kind":"grant","acquired":true,"shares":108240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to such option vest on October 1, 2021 and 1/48th of the shares subject to the option vest in substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":108240,"derivative":{"exercise_price":24.32,"expiration_date":"2030-10-08","underlying":"Common Stock","underlying_shares":108240},"source":{"system":"sec-edgar","filing":"0000899243-20-028074","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746473/000089924320028074/doc4.xml","form_type":"4"}}]}